Evidence in focus: POLAR3 Total Hip Solution delivers excellent performance with high survivorship at 10 years

English

English
Español (ES-INT)
Portuguêses Brasil (PT-BR)
日本語

AUTHOR(S): Global Clinical & Medical Affairs, S+N

POLARSTEM and R3 with OXINIUM showed significant reduction in revision rate, when compared with class average (p=0.01)

5 April 2022

Treatment concepts & technologies,
Cementless implant,
Hip,
Osteoarthritis / arthrosis,
Joint reconstruction,
Primary arthroplasty,
Reconstruction,
OXINIUM™,
POLAR3™,
POLARSTEM™,
R3™

3408
1

Download Evidence in focus: POLAR3 Total Hip Solution delivers excellent performance with high survivorship at 10 years

Download (PDF 37 KB)

Share
Download

2008 - 2022 Smith & Nephew Plc. ◊Trademark of Smith+Nephew Product information is for educational purposes only, and not all products or indications are licensed in every country.

Evidence in focus: POLAR3 Total Hip Solution delivers excellent performance with high survivorship at 10 years

AUTHOR(S): Global Clinical & Medical Affairs, S+N

POLARSTEM and R3 with OXINIUM showed significant reduction in revision rate, when compared with class average (p=0.01)

5 April 2022

Download Evidence in focus: POLAR3 Total Hip Solution delivers excellent performance with high survivorship at 10 years

Related resources & events

Related surgical technique guides